Fierce Biotech Mix Logo.png Fierce Biotech Mix Logo.png
Webinar

Rethinking Clinical Development Sourcing: What the Data Reveals

ET
60 Minutes

Clinical development sourcing strategies continue to evolve as sponsors balance increasingly complex trials, expanding technology requirements, cost pressures and the need for greater operational efficiency. Yet despite the widespread use of different sourcing models, there has been limited empirical evidence comparing how these approaches influence trial timelines, quality and cost. 

New research conducted in collaboration with the Tufts Center for the Study of Drug Development and a working group of 13 leading pharmaceutical companies examines data from 81 development programs and 133 clinical trials to provide a clearer view of how sourcing decisions translate into trial performance. 

This webinar will explore key findings from the research and consider what they reveal about the changing relationship between sponsors, CROs and other clinical development partners. 

The discussion will examine: 

  • What drives sponsors to select different clinical development sourcing models 

  • How sourcing approaches can influence study timelines, quality and cost 

  • The impact of vendor quantity and coordination on trial performance 

  • What is driving technology investment across clinical development 

  • How sponsor and CRO operating models are evolving alongside changing trial needs 

Explore what the data reveals about clinical development sourcing and the considerations shaping the next generation of sponsor strategies.

Speakers

james man

James Man

Managing Director, R&D Advisory
Syneos Health

James has served the pharmaceutical and life sciences industries for over 17 years as a management consultant at Kinapse and now at Syneos Health. He has led a wide variety of projects across R&D, with a focus in leading transformational projects in Clinical Development, Medical Affairs and R&D Operations. He excels in facilitation, communication, change alignment and stakeholder buy-in around operating model design, process reengineering, governance and enterprise transformation.​

zak_smith.png

Zak Smith

Assistant Director, Data Sciences & Analytics
Tufts Center for the Study of Drug Development (CSDD)
Zak Smith works on a variety of Tufts CSDD studies focusing on drug development performance, efficiency, economics, and innovation adoption. His research often focuses on protocol complexity, clinical trial participant and site burden, and diversity and representation in clinical trials. He also leads the analysis for the PACT consortium, which collects granular data on the use of DCT solutions and metrics of performance for the trials that deploy them. Many of these projects involve creating, compiling, and analyzing very large datasets. Zak completed his BS at Florida Southern College and received his MA from Brandeis University. He has worked as a research assistant at Harvard University and at the University of Massachusetts and began at Tufts CSDD as a research analyst.
manfred_weiler.jpg

Manfred Weiler

Head of Europe Strategic & Biotech Partnerships
Syneos Health
Dr. Manfred Weiler is a life sciences executive at Syneos Health Clinical Solutions with more than 20 years of experience working with biotech and pharmaceutical customers. Through leadership roles in business development and alliance management, he has built partnerships across the industry and seen how companies’ approaches to outsourcing have evolved over the past two decades. He holds a PhD in molecular biology from the University of Bonn.

Register here!

Already registered? Click here to login.
Date/Time:
ET